A systematic review on Ivermectin

Sathoori Manasa * and B. Shireesha

Department of pharmacy, Joginpally B R pharmacy college, Hyderabad, telangana, India.
 
Review
International Journal of Science and Research Archive, 2023, 08(01), 099-110.
Article DOI: 10.30574/ijsra.2023.8.1.0357
Publication history: 
Received on 24 November 2022; revised on 01 January 2023; accepted on 04 January 2023
 
Abstract: 
Ivermectin works as genocide on a variety of parasites. Despite being a macrocyclic lactone, nothing is known about its antibacterial activity, maybe as a result of the need for micromolar concentrations to operate therapeutically at the tissue level. Staphylococcus aureus is one of the pathogenic bacteria of significant medical importance that causes a multitude of diseases in a variety of hosts, including both people and animals. It is one of the most pathogenic organisms, according to some. S. aureus is now resistant to the majority of the current medicines due to the advent of methicillin resistance, making treatment even more challenging. Therefore, the need for alternative anti-staphylococcal medicines is urgent.
 
Keywords: 
Ivermectin; Bacteria; COVID-19; SARS-CoV-2
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0